{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T14:09:08Z","timestamp":1772028548174,"version":"3.50.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00284-026-04723-6","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:40:54Z","timestamp":1770288054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reprogramming Gastric Cancer Therapy: A Microbiome-Guided Approach to Precision Oncology"],"prefix":"10.1007","volume":"83","author":[{"given":"Pourya","family":"Gholizadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elnaz","family":"Faghfuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"issue":"5","key":"4723_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006003","volume":"96","author":"Z Liu","year":"2017","unstructured":"Liu Z, Feng F, Guo M, Liu S, Zheng G, Xu G et al (2017) Distal gastrectomy versus total gastrectomy for distal gastric cancer. Medicine (Baltimore) 96(5):e6003","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"4723_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal\u2010type carcinoma: an attempt at a histo\u2010clinical classification. Acta Pathol Microbiol Scand 64(1):31\u201349","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"null","key":"4723_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2147\/CMAR.S149619","volume":"10","author":"R Sitarz","year":"2018","unstructured":"Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP (2018) Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res 10(null):239\u2013248","journal-title":"Cancer Manag Res"},{"issue":"5","key":"4723_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa1909666","volume":"382","author":"IJ Choi","year":"2020","unstructured":"Choi IJ, Kim CG, Lee JY, Kim YI, Kook MC, Park B et al (2020) Family history of gastric cancer and Helicobacter pylori treatment. N Engl J Med 382(5):427\u201336","journal-title":"N Engl J Med"},{"key":"4723_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/5584_2019_363","volume":"1149","author":"M Hatakeyama","year":"2019","unstructured":"Hatakeyama M (2019) Malignant Helicobacter pylori-associated diseases: gastric cancer and MALT lymphoma. Adv Exp Med Biol 1149:135\u2013149","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"4723_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1053\/j.gastro.2019.10.019","volume":"158","author":"S Kumar","year":"2020","unstructured":"Kumar S, Metz DC, Ellenberg S, Kaplan DE, Goldberg DS (2020) Risk factors and incidence of gastric cancer after detection of Helicobacter pylori infection: a large cohort study. Gastroenterology 158(3):527\u201336 e7","journal-title":"Gastroenterology"},{"issue":"1","key":"4723_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16289-2","volume":"7","author":"N Castano-Rodriguez","year":"2017","unstructured":"Castano-Rodriguez N, Goh KL, Fock KM, Mitchell HM, Kaakoush NO (2017) Dysbiosis of the microbiome in gastric carcinogenesis. Sci Rep 7(1):15957","journal-title":"Sci Rep"},{"issue":"6","key":"4723_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/hel.12145","volume":"19","author":"CS Eun","year":"2014","unstructured":"Eun CS, Kim BK, Han DS, Kim SY, Kim KM, Choi BY et al (2014) Differences in gastric mucosal microbiota profiling in patients with chronic gastritis, intestinal metaplasia, and gastric cancer using pyrosequencing methods. Helicobacter 19(6):407\u201316","journal-title":"Helicobacter"},{"key":"4723_CR9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ebiom.2018.12.034","volume":"40","author":"X Liu","year":"2019","unstructured":"Liu X, Shao L, Liu X, Ji F, Mei Y, Cheng Y et al (2019) Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer. EBioMedicine 40:336\u201348","journal-title":"EBioMedicine"},{"issue":"3","key":"4723_CR10","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1073\/pnas.0506655103","volume":"103","author":"EM Bik","year":"2006","unstructured":"Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F et al (2006) Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A 103(3):732\u20137","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"4723_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002836","volume":"3","author":"AF Andersson","year":"2008","unstructured":"Andersson AF, Lindberg M, Jakobsson H, Backhed F, Nyren P, Engstrand L (2008) Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One 3(7):e2836","journal-title":"PLoS One"},{"issue":"4","key":"4723_CR12","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/ismej.2010.149","volume":"5","author":"A Maldonado-Contreras","year":"2011","unstructured":"Maldonado-Contreras A, Goldfarb KC, Godoy-Vitorino F, Karaoz U, Contreras M, Blaser MJ et al (2011) Structure of the human gastric bacterial community in relation to Helicobacter pylori status. ISME J 5(4):574\u2013579","journal-title":"ISME J"},{"issue":"7","key":"4723_CR13","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/ismej.2013.33","volume":"7","author":"EC von Rosenvinge","year":"2013","unstructured":"von Rosenvinge EC, Song Y, White JR, Maddox C, Blanchard T, Fricke WF (2013) Immune status, antibiotic medication and pH are associated with changes in the stomach fluid microbiota. ISME J 7(7):1354\u201366","journal-title":"ISME J"},{"issue":"Pt 4","key":"4723_CR14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1099\/jmm.0.007302-0","volume":"58","author":"J Dicksved","year":"2009","unstructured":"Dicksved J, Lindberg M, Rosenquist M, Enroth H, Jansson JK, Engstrand L (2009) Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol 58(Pt 4):509\u2013516","journal-title":"J Med Microbiol"},{"issue":"3","key":"4723_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/MEG.0000000000000542","volume":"28","author":"L Wang","year":"2016","unstructured":"Wang L, Zhou J, Xin Y, Geng C, Tian Z, Yu X et al (2016) Bacterial overgrowth and diversification of microbiota in gastric cancer. Eur J Gastroenterol Hepatol 28(3):261\u20136","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"4723_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep04202","volume":"4","author":"F Aviles-Jimenez","year":"2014","unstructured":"Aviles-Jimenez F, Vazquez-Jimenez F, Medrano-Guzman R, Mantilla A, Torres J (2014) Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer. Sci Rep 4(1):4202","journal-title":"Sci Rep"},{"issue":"5","key":"4723_CR17","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1586\/17474124.2015.1001745","volume":"9","author":"A Leung","year":"2015","unstructured":"Leung A, Tsoi H, Yu J (2015) Fusobacterium and escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening. Expert Rev Gastroenterol Hepatol 9(5):651\u2013657","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"10","key":"4723_CR18","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.4014\/jmb.1503.03033","volume":"25","author":"KJ Han","year":"2015","unstructured":"Han KJ, Lee NK, Park H, Paik HD (2015) Anticancer and anti-inflammatory activity of probiotic Lactococcus lactis NK34. J Microbiol Biotechnol 25(10):1697\u20131701","journal-title":"J Microbiol Biotechnol"},{"issue":"1","key":"4723_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-21527-2","volume":"8","author":"M Kanayama","year":"2018","unstructured":"Kanayama M, Kato Y, Tsuji T, Konoeda Y, Hashimoto A, Kanauchi O et al (2018) Enhancement of immunomodulative effect of lactic acid bacteria on plasmacytoid dendritic cells with sucrose palmitate. Sci Rep 8(1):3147","journal-title":"Sci Rep"},{"issue":"11","key":"4723_CR20","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s12275-014-4355-y","volume":"52","author":"JE Kim","year":"2014","unstructured":"Kim JE, Kim MS, Yoon YS, Chung MJ, Yum DY (2014) Use of selected lactic acid bacteria in the eradication of Helicobacter pylori infection. J Microbiol 52(11):955\u2013962","journal-title":"J Microbiol"},{"key":"4723_CR21","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3389\/fmicb.2019.01261","volume":"10","author":"XH Chen","year":"2019","unstructured":"Chen XH, Wang A, Chu AN, Gong YH, Yuan Y (2019) Mucosa-associated microbiota in gastric cancer tissues compared with non-cancer tissues. Front Microbiol 10:1261","journal-title":"Front Microbiol"},{"issue":"1","key":"4723_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03650-x","volume":"20","author":"Y Yang","year":"2022","unstructured":"Yang Y, Dai D, Jin W, Huang Y, Zhang Y, Chen Y et al (2022) Microbiota and metabolites alterations in proximal and distal gastric cancer patients. J Transl Med 20(1):439","journal-title":"J Transl Med"},{"issue":"6","key":"4723_CR23","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/apt.15650","volume":"51","author":"M Rajilic-Stojanovic","year":"2020","unstructured":"Rajilic-Stojanovic M, Figueiredo C, Smet A, Hansen R, Kupcinskas J, Rokkas T et al (2020) Systematic review: gastric microbiota in health and disease. Aliment Pharmacol Ther 51(6):582\u2013602","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"4723_CR24","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3748\/wjg.v23.i10.1899","volume":"23","author":"N Ertz-Archambault","year":"2017","unstructured":"Ertz-Archambault N, Keim P, Von Hoff D (2017) Microbiome and pancreatic cancer: a comprehensive topic review of literature. World J Gastroenterol 23(10):1899\u2013908","journal-title":"World J Gastroenterol"},{"issue":"7","key":"4723_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/md15070224","volume":"15","author":"MF Cheng","year":"2017","unstructured":"Cheng MF, Lin CS, Chen YH, Sung PJ, Lin SR, Tong YW et al (2017) Inhibitory growth of oral squamous cell carcinoma cancer via bacterial prodigiosin. Mar Drugs 15(7):224","journal-title":"Mar Drugs"},{"issue":"8","key":"4723_CR26","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/apt.15675","volume":"51","author":"B Gantuya","year":"2020","unstructured":"Gantuya B, El Serag HB, Matsumoto T, Ajami NJ, Uchida T, Oyuntsetseg K et al (2020) Gastric mucosal microbiota in a Mongolian population with gastric cancer and precursor conditions. Aliment Pharmacol Ther 51(8):770\u201380","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"4723_CR27","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1136\/gutjnl-2017-314281","volume":"67","author":"OO Coker","year":"2018","unstructured":"Coker OO, Dai Z, Nie Y, Zhao G, Cao L, Nakatsu G et al (2018) Mucosal Microbiome dysbiosis in gastric carcinogenesis. Gut 67(6):1024\u20131032","journal-title":"Gut"},{"issue":"3","key":"4723_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1046\/j.1365-2036.2001.00888.x","volume":"15","author":"S Sanduleanu","year":"2001","unstructured":"Sanduleanu S, Jonkers D, De Bruine A, Hameeteman W, Stockbrugger RW (2001) Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa. Aliment Pharmacol Ther 15(3):379\u201388","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"4723_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006573","volume":"13","author":"JM Noto","year":"2017","unstructured":"Noto JM, Peek RM Jr. (2017) The gastric microbiome, its interaction with Helicobacter pylori, and its potential role in the progression to stomach cancer. PLoS Pathog 13(10):e1006573","journal-title":"PLoS Pathog"},{"issue":"1","key":"4723_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03650-x","volume":"20","author":"Y Yang","year":"2022","unstructured":"Yang Y, Dai D, Jin W, Huang Y, Zhang Y, Chen Y et al (2022) Microbiota and metabolites alterations in proximal and distal gastric cancer patients. J Transl Med 20(1):439","journal-title":"J Transl Med"},{"issue":"12","key":"4723_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04396-y","volume":"12","author":"D Dai","year":"2021","unstructured":"Dai D, Yang Y, Yu J, Dang T, Qin W, Teng L et al (2021) Interactions between gastric microbiota and metabolites in gastric cancer. Cell Death Dis 12(12):1104","journal-title":"Cell Death Dis"},{"issue":"10","key":"4723_CR32","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrmicro3344","volume":"12","author":"P Louis","year":"2014","unstructured":"Louis P, Hold GL, Flint HJ (2014) The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 12(10):661\u2013672","journal-title":"Nat Rev Microbiol"},{"issue":"16","key":"4723_CR33","doi-asserted-by":"publisher","first-page":"7857","DOI":"10.3390\/ijms26167857","volume":"26","author":"C Thoda","year":"2025","unstructured":"Thoda C, Touraki M (2025) Molecular mechanisms of probiotic action against gastrointestinal cancers. Int J Mol Sci 26(16):7857","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4723_CR34","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.chom.2022.08.016","volume":"30","author":"P Wilmes","year":"2022","unstructured":"Wilmes P, Martin-Gallausiaux C, Ostaszewski M, Aho VTE, Novikova PV, Laczny CC et al (2022) The gut Microbiome molecular complex in human health and disease. Cell Host Microbe 30(9):1201\u20131206","journal-title":"Cell Host Microbe"},{"issue":"5","key":"4723_CR35","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1007\/s10120-020-01065-5","volume":"23","author":"S Kaji","year":"2020","unstructured":"Kaji S, Irino T, Kusuhara M, Makuuchi R, Yamakawa Y, Tokunaga M et al (2020) Metabolomic profiling of gastric cancer tissues identified potential biomarkers for predicting peritoneal recurrence. Gastric Cancer 23(5):874\u201383","journal-title":"Gastric Cancer"},{"issue":"11","key":"4723_CR36","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.1158\/0008-5472.CAN-08-4806","volume":"69","author":"A Hirayama","year":"2009","unstructured":"Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H et al (2009) Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 69(11):4918\u201325","journal-title":"Cancer Res"},{"issue":"2","key":"4723_CR37","first-page":"431","volume":"26","author":"H Song","year":"2011","unstructured":"Song H, Wang L, Liu HL, Wu XB, Wang HS, Liu ZH et al (2011) Tissue metabolomic fingerprinting reveals metabolic disorders associated with human gastric cancer morbidity. Oncol Rep 26(2):431\u2013438","journal-title":"Oncol Rep"},{"issue":"18","key":"4723_CR38","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1158\/0008-5472.CAN-20-0754","volume":"80","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, Clima R, Busch J, Rabien A, Kilic E, Villegas SL et al (2020) Decreased mitochondrial DNA content drives OXPHOS dysregulation in chromophobe renal cell carcinoma. Cancer Res 80(18):3830\u201340","journal-title":"Cancer Res"},{"issue":"null","key":"4723_CR39","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.2147\/OTT.S245663","volume":"13","author":"G Pan","year":"2020","unstructured":"Pan G, Ma Y, Suo J, Li W, Zhang Y, Qin S et al (2020) Discovering biomarkers in peritoneal metastasis of gastric cancer by metabolomics. Onco Targets Ther 13(null):7199\u20137211","journal-title":"Onco Targets Ther"},{"key":"4723_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2019.105539","volume":"197","author":"W Lee","year":"2020","unstructured":"Lee W, Um J, Hwang B, Lee YC, Chung BC, Hong J (2020) Assessing the progression of gastric cancer via profiling of histamine, histidine, and bile acids in gastric juice using LC-MS\/MS. J Steroid Biochem Mol Biol 197:105539","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"4723_CR41","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/S1470-2045(18)30952-5","volume":"20","author":"JL McQuade","year":"2019","unstructured":"McQuade JL, Daniel CR, Helmink BA, Wargo JA (2019) Modulating the microbiome to improve therapeutic response in cancer. Lancet Oncol 20(2):e77\u2013e91","journal-title":"Lancet Oncol"},{"issue":"1","key":"4723_CR42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1194\/jlr.M020313","volume":"53","author":"JM Ridlon","year":"2012","unstructured":"Ridlon JM, Hylemon PB (2012) Identification and characterization of two bile acid coenzyme A transferases from clostridium scindens, a bile acid 7alpha-dehydroxylating intestinal bacterium. J Lipid Res 53(1):66\u201376","journal-title":"J Lipid Res"},{"issue":"7827","key":"4723_CR43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41586-020-2541-0","volume":"586","author":"E Kadosh","year":"2020","unstructured":"Kadosh E, Snir-Alkalay I, Venkatachalam A, May S, Lasry A, Elyada E et al (2020) The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic. Nature 586(7827):133\u20138","journal-title":"Nature"},{"issue":"1","key":"4723_CR44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.7150\/thno.65302","volume":"12","author":"CW Png","year":"2022","unstructured":"Png CW, Lee WJJ, Chua SJ, Zhu F, Gastric C, Yeoh KG et al (2022) Mucosal Microbiome associates with progression to gastric cancer. Theranostics 12(1):48\u201358","journal-title":"Theranostics"},{"issue":"2","key":"4723_CR45","volume":"1872","author":"K Vinasco","year":"2019","unstructured":"Vinasco K, Mitchell HM, Kaakoush NO, Castano-Rodriguez N (2019) Microbial carcinogenesis: lactic acid bacteria in gastric cancer. Biochimica et Biophysica Acta (BBA) 1872(2):188309","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"4723_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00997","volume":"11","author":"Z Wang","year":"2020","unstructured":"Wang Z, Gao X, Zeng R, Wu Q, Sun H, Wu W et al (2020) Changes of the gastric mucosal microbiome associated with histological stages of gastric carcinogenesis. Front Microbiol 11:997","journal-title":"Front Microbiol"},{"issue":"2","key":"4723_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.29","volume":"4","author":"C Marques","year":"2013","unstructured":"Marques C, Oliveira CS, Alves S, Chaves SR, Coutinho OP, Corte-Real M et al (2013) Acetate-induced apoptosis in colorectal carcinoma cells involves lysosomal membrane permeabilization and cathepsin D release. Cell Death Dis 4(2):e507","journal-title":"Cell Death Dis"},{"key":"4723_CR48","doi-asserted-by":"crossref","unstructured":"Xia Y, Zhang XL, Jin F, Wang QX, Xiao R, Hao ZH et al (2016) Apoptotic effect of sodium acetate on a human gastric adenocarcinoma epithelial cell line. Genet Mol Res ;15(4)","DOI":"10.4238\/gmr.15048375"},{"issue":"1","key":"4723_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10120-018-0867-1","volume":"22","author":"H Maleki Kakelar","year":"2019","unstructured":"Maleki Kakelar H, Barzegari A, Dehghani J, Hanifian S, Saeedi N, Barar J et al (2019) Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination. Gastric Cancer 22(1):23\u201336","journal-title":"Gastric Cancer"},{"issue":"5","key":"4723_CR50","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41568-020-0255-0","volume":"20","author":"U Harjes","year":"2020","unstructured":"Harjes U (2020) Tumour-reactive T cells work remotely using IFN\u03b3. Nat Rev Cancer 20(5):261","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"4723_CR51","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.immuni.2020.03.002","volume":"52","author":"N Satoh-Takayama","year":"2020","unstructured":"Satoh-Takayama N, Kato T, Motomura Y, Kageyama T, Taguchi-Atarashi N, Kinoshita-Daitoku R et al (2020) Bacteria-induced group 2 innate lymphoid cells in the stomach provide immune protection through induction of IgA. Immunity 52(4):635\u2013649 e4","journal-title":"Immunity"},{"issue":"5","key":"4723_CR52","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/j.1462-5822.2007.01108.x","volume":"10","author":"A Lundin","year":"2008","unstructured":"Lundin A, Bok CM, Aronsson L, Bj\u00f6rkholm B, Gustafsson J\u00c5, Pott S et al (2008) Gut flora, Toll-like receptors and nuclear receptors: a tripartite communication that tunes innate immunity in large intestine. Cell Microbiol 10(5):1093\u2013103","journal-title":"Cell Microbiol"},{"issue":"2","key":"4723_CR53","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1053\/j.gastro.2020.11.041","volume":"160","author":"V Matson","year":"2021","unstructured":"Matson V, Chervin CS, Gajewski TF (2021) Cancer and the microbiome-influence of the commensal microbiota on cancer, immune responses, and immunotherapy. Gastroenterology 160(2):600\u2013613","journal-title":"Gastroenterology"},{"issue":"8","key":"4723_CR54","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/ni.3780","volume":"18","author":"JM Blander","year":"2017","unstructured":"Blander JM, Longman RS, Iliev ID, Sonnenberg GF, Artis D (2017) Regulation of inflammation by microbiota interactions with the host. Nat Immunol 18(8):851\u2013860","journal-title":"Nat Immunol"},{"issue":"10","key":"4723_CR55","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1158\/2326-6066.CIR-22-0107","volume":"10","author":"R Peng","year":"2022","unstructured":"Peng R, Liu S, You W, Huang Y, Hu C, Gao Y et al (2022) Gastric microbiome alterations are associated with decreased CD8\u2009+\u2009tissue-resident memory T cells in the tumor microenvironment of gastric cancer. Cancer Immunol Res 10(10):1224\u201340","journal-title":"Cancer Immunol Res"},{"key":"4723_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00533","volume":"10","author":"Z Ling","year":"2019","unstructured":"Ling Z, Shao L, Liu X, Cheng Y, Yan C, Mei Y et al (2019) Regulatory T cells and plasmacytoid dendritic cells within the tumor microenvironment in gastric cancer are correlated with gastric microbiota dysbiosis: a preliminary study. Front Immunol 10:533","journal-title":"Front Immunol"},{"issue":"6264","key":"4723_CR57","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M V\u00e9tizou","year":"2015","unstructured":"V\u00e9tizou M, Pitt JM, Daill\u00e8re R, Lepage P, Waldschmitt N, Flament C et al (2015) Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350(6264):1079\u201384","journal-title":"Science"},{"issue":"10","key":"4723_CR58","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1158\/2326-6066.CIR-19-1014","volume":"8","author":"Z Peng","year":"2020","unstructured":"Peng Z, Cheng S, Kou Y, Wang Z, Jin R, Hu H et al (2020) The gut microbiome is associated with clinical response to anti-PD-1\/PD-L1 immunotherapy in gastrointestinal cancer. Cancer Immunol Res 8(10):1251\u201361","journal-title":"Cancer Immunol Res"},{"key":"4723_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116416","volume":"173","author":"E Faghfuri","year":"2024","unstructured":"Faghfuri E, Gholizadeh P (2024) The role of Akkermansia muciniphila in colorectal cancer: a double-edged sword of treatment or disease progression? Biomed Pharmacother 173:116416","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"4723_CR60","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001435","volume":"70","author":"A Hasani","year":"2021","unstructured":"Hasani A, Ebrahimzadeh S, Hemmati F, Khabbaz A, Hasani A, Gholizadeh P (2021) The role of Akkermansia muciniphila in obesity, diabetes and atherosclerosis. J Med Microbiol 70(10):001435","journal-title":"J Med Microbiol"},{"issue":"6464","key":"4723_CR61","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1126\/science.aaw2719","volume":"366","author":"F Legoux","year":"2019","unstructured":"Legoux F, Bellet D, Daviaud C, El Morr Y, Darbois A, Niort K et al (2019) Microbial metabolites control the thymic development of mucosal-associated invariant T cells. Science 366(6464):494\u20139","journal-title":"Science"},{"key":"4723_CR62","doi-asserted-by":"publisher","first-page":"612202","DOI":"10.3389\/fimmu.2020.612202","volume":"11","author":"Q Qiu","year":"2020","unstructured":"Qiu Q, Lin Y, Ma Y, Li X, Liang J, Chen Z et al (2020) Exploring the emerging role of the gut microbiota and tumor microenvironment in cancer immunotherapy. Front Immunol 11:612202","journal-title":"Front Immunol"},{"issue":"1","key":"4723_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05901-2","volume":"9","author":"M Sun","year":"2018","unstructured":"Sun M, Wu W, Chen L, Yang W, Huang X, Ma C et al (2018) Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis. Nat Commun 9(1):3555","journal-title":"Nat Commun"},{"issue":"1","key":"4723_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18262-6","volume":"11","author":"W Yang","year":"2020","unstructured":"Yang W, Yu T, Huang X, Bilotta AJ, Xu L, Lu Y et al (2020) Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun 11(1):4457","journal-title":"Nat Commun"},{"key":"4723_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104347","volume":"86","author":"Y Yao","year":"2022","unstructured":"Yao Y, Sun S, Gu J, Ni H, Zhong K, Xu Q et al (2022) Roux-en-Y reconstruction alleviates radical gastrectomy-induced colitis via down-regulation of the butyrate\/NLRP3 signaling pathway. EBioMedicine 86:104347","journal-title":"EBioMedicine"},{"issue":"1","key":"4723_CR66","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ccell.2016.05.016","volume":"30","author":"F Pietrocola","year":"2016","unstructured":"Pietrocola F, Pol J, Vacchelli E, Rao S, Enot DP, Baracco EE et al (2016) Caloric restriction mimetics enhance anticancer immunosurveillance. Cancer Cell 30(1):147\u2013160","journal-title":"Cancer Cell"},{"key":"4723_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.612202","volume":"11","author":"Q Qiu","year":"2021","unstructured":"Qiu Q, Lin Y, Ma Y, Li X, Liang J, Chen Z et al (2021) Exploring the emerging role of the gut microbiota and tumor microenvironment in cancer immunotherapy. Front Immunol 11:612202","journal-title":"Front Immunol"},{"issue":"5","key":"4723_CR68","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cmet.2021.03.002","volume":"33","author":"Y He","year":"2021","unstructured":"He Y, Fu L, Li Y, Wang W, Gong M, Zhang J et al (2021) Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8\u2009+\u2009T cell immunity. Cell Metab 33(5):988-1000. e7","journal-title":"Cell Metab"},{"key":"4723_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1110787","volume":"13","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, Hu Y, Tang J, Xu W, Zhu W, Zhang W (2023) The implication of gut microbiota in recovery from gastrointestinal surgery. Front Cell Infect Microbiol 13:1110787","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"4723_CR70","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrgastro.2016.139","volume":"14","author":"K Guyton","year":"2017","unstructured":"Guyton K, Alverdy JC (2017) The gut microbiota and gastrointestinal surgery. Nat Rev Gastroenterol Hepatol 14(1):43\u201354","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4723_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/srep20701","volume":"6","author":"CH Tseng","year":"2016","unstructured":"Tseng CH, Lin JT, Ho HJ, Lai ZL, Wang CB, Tang SL et al (2016) Gastric microbiota and predicted gene functions are altered after subtotal gastrectomy in patients with gastric cancer. Sci Rep 6:20701","journal-title":"Sci Rep"},{"issue":"11","key":"4723_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206930","volume":"13","author":"XH Lin","year":"2018","unstructured":"Lin XH, Huang KH, Chuang WH, Luo JC, Lin CC, Ting PH et al (2018) The long term effect of metabolic profile and microbiota status in early gastric cancer patients after subtotal gastrectomy. PLoS One 13(11):e0206930","journal-title":"PLoS One"},{"issue":"23","key":"4723_CR73","doi-asserted-by":"publisher","first-page":"7480","DOI":"10.3748\/wjg.v20.i23.7480","volume":"20","author":"M \u0141awniczak","year":"2014","unstructured":"\u0141awniczak M, Gawin A, Jaroszewicz-Heigelmann H, Rogoza-Mateja W, Raszeja-Wyszomirska J, Bia\u0142ek A et al (2014) Synchronous and metachronous neoplasms in gastric cancer patients: a 23-year study. World J Gastroenterol 20(23):7480\u20137487","journal-title":"World J Gastroenterol"},{"issue":"8","key":"4723_CR74","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1136\/gutjnl-2019-319188","volume":"69","author":"PP Erawijantari","year":"2020","unstructured":"Erawijantari PP, Mizutani S, Shiroma H, Shiba S, Nakajima T, Sakamoto T et al (2020) Influence of gastrectomy for gastric cancer treatment on faecal microbiome and metabolome profiles. Gut 69(8):1404\u201315","journal-title":"Gut"},{"issue":"3","key":"4723_CR75","doi-asserted-by":"publisher","first-page":"568","DOI":"10.7150\/jca.29072","volume":"10","author":"C Zheng","year":"2019","unstructured":"Zheng C, Chen T, Wang Y, Gao Y, Kong Y, Liu Z et al (2019) A randomised trial of probiotics to reduce severity of physiological and microbial disorders induced by partial gastrectomy for patients with gastric cancer. J Cancer 10(3):568\u201376","journal-title":"J Cancer"},{"key":"4723_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2021.111574","volume":"96","author":"G Liu","year":"2022","unstructured":"Liu G, Cao S, Liu X, Li Z, Tian Y, Zhang X et al (2022) Effect of perioperative probiotic supplements on postoperative short-term outcomes in gastric cancer patients receiving neoadjuvant chemotherapy: a double-blind, randomized controlled trial. Nutrition 96:111574","journal-title":"Nutrition"},{"key":"4723_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.781697","volume":"11","author":"N Li","year":"2021","unstructured":"Li N, Bai C, Zhao L, Sun Z, Ge Y, Li X (2021) The relationship between gut microbiome features and chemotherapy response in gastrointestinal cancer. Front Oncol 11:781697","journal-title":"Front Oncol"},{"issue":"10111","key":"4723_CR78","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(17)31827-5","volume":"390","author":"YK Kang","year":"2017","unstructured":"Kang YK, Boku N, Satoh T, Ryu MH, Chao Y, Kato K et al (2017) Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 390(10111):2461\u201371","journal-title":"Lancet"},{"issue":"6","key":"4723_CR79","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1001\/jamaoncol.2021.0275","volume":"7","author":"J Chao","year":"2021","unstructured":"Chao J, Fuchs CS, Shitara K, Tabernero J, Muro K, Van Cutsem E et al (2021) Assessment of pembrolizumab therapy for the treatment of microsatellite instability-high gastric or gastroesophageal junction cancer among patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 clinical trials. JAMA Oncol 7(6):895\u2013902","journal-title":"JAMA Oncol"},{"issue":"6371","key":"4723_CR80","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV et al (2018) Gut Microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359(6371):97\u2013103","journal-title":"Science"},{"issue":"3","key":"4723_CR81","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","volume":"170","author":"T Yu","year":"2017","unstructured":"Yu T, Guo F, Yu Y, Sun T, Ma D, Han J et al (2017) Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell 170(3):548\u201363e16","journal-title":"Cell"},{"issue":"7","key":"4723_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1312","volume":"13","author":"Z Han","year":"2023","unstructured":"Han Z, Cheng S, Dai D, Kou Y, Zhang X, Li F et al (2023) The gut microbiome affects response of treatments in HER2-negative advanced gastric cancer. Clin Transl Med 13(7):e1312","journal-title":"Clin Transl Med"},{"key":"4723_CR83","doi-asserted-by":"crossref","unstructured":"Sunakawa Y, Matoba R, Inoue E, Sakamoto Y, Kawabata R, Ishiguro A et al (2021) Genomic pathway of gut Microbiome to predict efficacy of nivolumab in advanced gastric cancer: DELIVER trial (JACCRO GC-08). American Society of Clinical Oncology","DOI":"10.1200\/JCO.2021.39.3_suppl.161"},{"key":"4723_CR84","doi-asserted-by":"crossref","unstructured":"Sunakawa Y, Matoba R, Takayama T, Okumura N, Sugimoto N, Miura K et al (2022) Host-related biomarkers including gut Microbiome to predict toxicities of nivolumab in advanced gastric cancer: DELIVER trial (JACCRO GC-08). American Society of Clinical Oncology","DOI":"10.1200\/JCO.2022.40.4_suppl.245"},{"key":"4723_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.937874","volume":"13","author":"L Zhang","year":"2022","unstructured":"Zhang L, Jin Q, Chai D, Kuang T, Li C, Guan Y et al (2022) The correlation between probiotic use and outcomes of cancer patients treated with immune checkpoint inhibitors. Front Pharmacol 13:937874","journal-title":"Front Pharmacol"},{"issue":"16","key":"4723_CR86","doi-asserted-by":"publisher","first-page":"16876","DOI":"10.1002\/cam4.6313","volume":"12","author":"J Arai","year":"2023","unstructured":"Arai J, Niikura R, Hayakawa Y, Suzuki N, Honda T, Okamura T et al (2023) Association of probiotic use with nivolumab effectiveness against various cancers: a multicenter retrospective cohort study. Cancer Med 12(16):16876\u201380","journal-title":"Cancer Med"},{"issue":"7Supplement","key":"4723_CR87","doi-asserted-by":"publisher","first-page":"5894","DOI":"10.1158\/1538-7445.AM2023-5894","volume":"83","author":"NM Melendez-Vazquez","year":"2023","unstructured":"Melendez-Vazquez NM, Sohoni S, Van Wieren A, Fueyo J, Gomez-Manzano C, Godoy-Vitorino F (2023) Changes in the gut microbiota associated with oncolytic virotherapy efficacy in a gastric cancer murine model. Cancer Res 83(7Supplement):5894","journal-title":"Cancer Res"},{"issue":"1","key":"4723_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01406-7","volume":"8","author":"L-Y Zhao","year":"2023","unstructured":"Zhao L-Y, Mei J-X, Yu G, Lei L, Zhang W-H, Liu K et al (2023) Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications. Signal Transduct Target Ther 8(1):201","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"4723_CR89","doi-asserted-by":"publisher","first-page":"344","DOI":"10.18632\/oncotarget.27873","volume":"12","author":"S Matsumura","year":"2021","unstructured":"Matsumura S, Nakamori M, Tsuji T, Kato T, Nakamura M, Ojima T et al (2021) Oncolytic virotherapy with SOCS3 enhances viral replicative potency and Oncolysis for gastric cancer. Oncotarget 12(4):344","journal-title":"Oncotarget"},{"issue":"2","key":"4723_CR90","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/ijc.27681","volume":"132","author":"T Tsuji","year":"2013","unstructured":"Tsuji T, Nakamori M, Iwahashi M, Nakamura M, Ojima T, Iida T et al (2013) An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer. Int J Cancer 132(2):485\u2013494","journal-title":"Int J Cancer"},{"key":"4723_CR91","first-page":"205","volume":"17","author":"K Sugawara","year":"2020","unstructured":"Sugawara K, Iwai M, Yajima S, Tanaka M, Yanagihara K, Seto Y et al (2020) Efficacy of a third-generation oncolytic herpes virus G47\u0394 in advanced stage models of human gastric cancer. Mol Ther 17:205\u201315","journal-title":"Mol Ther"},{"issue":"6","key":"4723_CR92","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3892\/ol.2021.12751","volume":"21","author":"T Kato","year":"2021","unstructured":"Kato T, Nakamori M, Matsumura S, Nakamura M, Ojima T, Fukuhara H et al (2021) Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer. Oncol Lett 21(6):490","journal-title":"Oncol Lett"},{"key":"4723_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmogo.2024.100048","author":"CA Cella","year":"2024","unstructured":"Cella CA, Ciardiello D, Gervaso L, van Laarhoven H, Nezi L, Catozzi C et al (2024) Role of the microbiome in the development and treatment of gastric cancer: an overview of the biological and clinical landscape. ESMO Gastrointestinal Oncology. https:\/\/doi.org\/10.1016\/j.esmogo.2024.100048","journal-title":"ESMO Gastrointestinal Oncology"},{"key":"4723_CR94","doi-asserted-by":"publisher","unstructured":"Xie M, Li X, Lau HC-H, Yu J (2025) The gut microbiota in cancer immunity and immunotherapy. Cell Mol Immunol 22:1012\u20131031. https:\/\/doi.org\/10.1038\/s41423-025-01326-2","DOI":"10.1038\/s41423-025-01326-2"},{"key":"4723_CR95","doi-asserted-by":"publisher","unstructured":"Li Q, Oduro PK, Guo R, Li R, Leng L, Kong X, Wang Q and Yang L (2022) Oncolytic viruses: immunotherapy drugs for gastrointestinal malignant tumors. Front Cell Infect Microbiol 12:921534. https:\/\/doi.org\/10.3389\/fcimb.2022.921534","DOI":"10.3389\/fcimb.2022.921534"},{"issue":"9","key":"4723_CR96","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","volume":"71","author":"P Malfertheiner","year":"2022","unstructured":"Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C et al (2022) Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report. Gut 71(9):1724\u20131762","journal-title":"Gut"},{"issue":"9","key":"4723_CR97","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1136\/gutjnl-2012-303018","volume":"62","author":"Y Chen","year":"2013","unstructured":"Chen Y, Segers S, Blaser MJ (2013) Association between Helicobacter pylori and mortality in the NHANES III study. Gut 62(9):1262\u20131269","journal-title":"Gut"},{"issue":"12","key":"4723_CR98","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1136\/gutjnl-2024-332815","volume":"73","author":"R Zeng","year":"2024","unstructured":"Zeng R, Gou H, Lau HCH, Yu J (2024) Stomach microbiota in gastric cancer development and clinical implications. Gut. https:\/\/doi.org\/10.1136\/gutjnl-2024-332815","journal-title":"Gut"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-04723-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-026-04723-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-04723-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:07:45Z","timestamp":1772024865000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-026-04723-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":98,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["4723"],"URL":"https:\/\/doi.org\/10.1007\/s00284-026-04723-6","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"25 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"All authors declare agreement and consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that ChatGPT (GPT-5, OpenAI) was used to improve the English language and writing style of this manuscript. The authors reviewed and verified all AI-generated suggestions to ensure the accuracy and integrity of the final content.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Declarations of AI Assistance"}},{"value":"This study was approved by the ethics committee of Ardabil University of Medical Sciences, with reference number IR.ARUMS.REC.1403.197.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}],"article-number":"150"}}